| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Adriana Albani | |
| Denis Ciato | |||
| P2860 | cites work | The cloning of a family of genes that encode the melanocortin receptors | Q24337156 |
| 60 YEARS OF POMC: Transcriptional and epigenetic regulation of POMC gene expression | Q26770534 | ||
| Reduced levels of hsp90 compromise steroid receptor action in vivo | Q45391521 | ||
| Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. | Q46289012 | ||
| Testicular Receptor-4: Novel Regulator of Glucocorticoid Resistance | Q46591508 | ||
| Genetics of Cushing's disease. | Q48162581 | ||
| Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease | Q48415480 | ||
| Opposite regulation of pro-opiomelanocortin gene transcription by glucocorticoids and CRH. | Q48502493 | ||
| Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome. | Q51305935 | ||
| Glucocorticoid receptor gene polymorphisms in ACTH-secreting pituitary tumours. | Q52547938 | ||
| Characterization of corticotropin-releasing hormone receptors on human pituitary corticotroph adenomas and their correlation with endogenous glucocorticoids. | Q54379779 | ||
| Cushing's syndrome | Q56228192 | ||
| A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease | Q62559186 | ||
| Monoclonality of corticotroph macroadenomas in Cushing's disease | Q67493133 | ||
| Glucocorticoid repression of pro-opiomelanocortin gene transcription | Q69449215 | ||
| Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors | Q73216943 | ||
| DIAGNOSIS OF CUSHING'S SYNDROME; SINGLE DOSE DEXAMETHASONE SUPPRESSION TEST | Q78446403 | ||
| Differential gene expression in ACTH -secreting and non-functioning pituitary tumors | Q80142052 | ||
| Tumor-Directed Therapeutic Targets in Cushing Disease | Q90391642 | ||
| GEOFFREY HARRIS AWARD 2019: Translational research in pituitary tumours | Q91204468 | ||
| The structural basis of direct glucocorticoid-mediated transrepression | Q27675411 | ||
| Cushing's syndrome | Q28262360 | ||
| Targeting the dynamic HSP90 complex in cancer | Q28288602 | ||
| HSP90 at the hub of protein homeostasis: emerging mechanistic insights | Q29616824 | ||
| HSP90 and the chaperoning of cancer | Q29617504 | ||
| Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin | Q29617507 | ||
| Cooperation between cyclin E and p27(Kip1) in pituitary tumorigenesis | Q33637242 | ||
| Minireview: Pathophysiological roles of the TR4 nuclear receptor: lessons learned from mice lacking TR4 | Q33701419 | ||
| The use of silymarin in the treatment of liver diseases | Q34104302 | ||
| Epidemiology of Cushing's syndrome | Q34137130 | ||
| Effects of corticotropin-releasing hormone and dexamethasone on proopiomelanocortin messenger RNA level in human corticotroph adenoma cells in vitro | Q34556784 | ||
| The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline | Q34760816 | ||
| The Hsp90 chaperone machinery | Q34774579 | ||
| Glucocorticoid receptors and Cushing's disease | Q34997028 | ||
| Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. | Q35105992 | ||
| Recurrent gain-of-function USP8 mutations in Cushing's disease | Q35146226 | ||
| The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease | Q35813265 | ||
| Antagonism between Nur77 and glucocorticoid receptor for control of transcription. | Q36573114 | ||
| The glucocorticoid receptor and its expression in the anterior pituitary and the adrenal cortex: a source of variation in hypothalamic-pituitary-adrenal axis function; implications for pituitary and adrenal tumors | Q36838985 | ||
| Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease | Q36884281 | ||
| Molecular mechanisms regulating glucocorticoid sensitivity and resistance | Q37171983 | ||
| The genome-wide mutational landscape of pituitary adenomas. | Q37400088 | ||
| Glucocorticoid sensitivity in health and disease | Q38147870 | ||
| Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations | Q38805238 | ||
| A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease | Q38911503 | ||
| Currently used and investigational drugs for Cushing´s disease | Q39022297 | ||
| Corticosteroid Inhibition of ACTH Secretion* | Q40141045 | ||
| Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids | Q41083075 | ||
| Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors | Q41142853 | ||
| Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. | Q41186916 | ||
| Dynamic responses of the adrenal steroidogenic regulatory network. | Q41293116 | ||
| Mutations in the deubiquitinase gene USP8 cause Cushing's disease | Q41716700 | ||
| Targeting the ERK pathway for the treatment of Cushing's disease | Q42317496 | ||
| Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors | Q43633880 | ||
| HDAC2 expression and variable number of repeats in exon 1 of the HDAC2 gene in corticotroph adenomas | Q44245156 | ||
| Clonal origin of pituitary adenomas | Q45035533 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P921 | main subject | glucocorticoid resistance | Q11798714 |
| P304 | page(s) | 21 | |
| P577 | publication date | 2020-01-29 | |
| P1433 | published in | Frontiers in Endocrinology | Q27723680 |
| P1476 | title | Molecular Mechanisms of Glucocorticoid Resistance in Corticotropinomas: New Developments and Drug Targets | |
| P478 | volume | 11 |
Search more.